Small Human StudySmall or uncontrolled human study. Results are preliminary.PeptidesPublished: March 16, 2026
Peptides in skincare: what do we know?
Researchers studied bioactive peptides used in skincare products and treatments. These peptides may influence the skin's extracellular matrix and repair. However, most evidence comes from lab and animal studies, and more human trials are needed to confirm their effectiveness.
Why it matters: Understanding peptides in skincare may help facial plastic surgeons and patients make informed decisions about treatments.
Most evidence is from in vitro and ex vivo studies, with limited regulatory oversight and few randomized clinical trials. Human studies are small and more research is needed to confirm findings.
Ex VivoSkin model or tissue experiments. Not in living humans.TretinoinPublished: March 9, 2026
Exosome Study Compares Skin Regeneration Effects
Researchers studied how two types of exosomes, derived from umbilical cord and fat tissue, affect human skin regeneration in a lab setting. They found that both types increased skin cell growth and reduced signs of aging, but in different ways. The study suggests that these exosomes may be useful for personalized skin rejuvenation.
Why it matters: This study may help us better understand how to use exosomes for skin rejuvenation and potentially develop new treatments for skin aging.
This study was conducted in a lab setting using human skin samples, and its findings may not directly translate to real-world skin care. Further research is needed to confirm these results.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.CeramidesPublished: February 24, 2026
Probiotics may help with skin aging and conditions in older adults
Researchers studied how probiotics affect skin aging and conditions in older adults. They found that probiotics may help restore balance to the skin's microbiome, improve skin barrier function, and reduce inflammation. However, more research is needed to confirm these findings.
Why it matters: Understanding the potential benefits of probiotics for skin health in older adults could lead to new strategies for managing age-related skin changes.
Several challenges remain regarding strain specificity, formulation stability, regulatory constraints on viable organisms, and the paucity of adequately powered randomized clinical trials.
In VitroCell or tissue culture experiments. No human or animal data.PeptidesPublished: February 21, 2026
Researchers Investigate Ethosomal Nanocarriers for Hydrophilic Peptide Encapsulation
A small study suggests that ethosomal nanocarriers may help improve the stability and controlled release of hydrolyzed collagen peptides, which are used in anti-aging skincare products. These peptides support skin hydration and elasticity. Researchers found that the peptides were effectively encapsulated and preserved within the nanocarriers.
Why it matters: This research may help improve the effectiveness of anti-aging skincare products containing hydrolyzed collagen peptides.
This study was conducted in lab experiments and its findings may not directly translate to human skin. Further research is needed to confirm these results.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: February 13, 2026
Vitamin E's potential benefits in dermatology
Researchers studied the effects of vitamin E on skin health, finding it may provide stress protection, normalize cellular homeostasis, and increase resistance to cellular damage. Vitamin E is a liposoluble antioxidant used for over 50 years in dermatology. The study discusses the relationship between oral and topical vitamin E and its potential benefits in dermatologic and systemic conditions.
Why it matters: Understanding vitamin E's potential benefits may help individuals make informed decisions about their skincare routines.
The abstract does not specify the type of systematic review, and the study's findings are based on recent research, but the exact studies are not mentioned.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: February 12, 2026
Ruxolitinib Cream May Help Control Mild to Moderate Atopic Dermatitis Symptoms
Researchers studied the long-term use of ruxolitinib cream for atopic dermatitis, a condition causing itchy skin. They found that patients using the cream as needed for up to 44 weeks experienced sustained disease and symptom control. However, more research is needed to confirm these findings.
Why it matters: This study may provide insights into effective long-term treatment options for patients with mild to moderate atopic dermatitis.
This study pooled data from two phase 3 trials, but the sample size was not specified. The study's duration was up to 44 weeks, and the results may not be generalizable to all patients with atopic dermatitis.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: February 4, 2026
Wharton's jelly stem cells may help rejuvenate skin
Researchers studied the secretome of Wharton's jelly mesenchymal stem cells to see if it could help rejuvenate skin. They found that it increased skin cell growth and improved skin elasticity in lab experiments. A small pilot study in humans also showed potential benefits, but more research is needed to confirm these findings.
Why it matters: This study may help us understand how to improve skin health and appearance, particularly as we age.
This study was small and only lasted one week, and the results need to be confirmed in larger, longer studies. The study was conducted in a lab and in a small group of humans, and more research is needed to understand its potential benefits and risks.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: February 1, 2026
Exosome-Based Therapies May Help Improve Skin Appearance
Researchers studied the effects of exosome-based therapies on skin rejuvenation in human populations. They found that these therapies may help improve skin hydration, elasticity, wrinkles, pores, pigmentation, and overall appearance in the short term. However, the evidence is limited due to methodological heterogeneity and lack of follow-up.
Why it matters: Understanding the potential benefits of exosome-based therapies could lead to new skincare treatments or products.
Most studies were not randomized, and there was methodological heterogeneity. The existing evidence is marred by a lack of follow-up and standardized reporting.
Animal StudyResults in animals only. May or may not translate to humans.Published: January 22, 2026
Afzelin May Help Protect Skin from UVA Damage
Researchers studied afzelin, a flavonoid with antioxidant properties, to see if it can protect skin from damage caused by UVA rays. They found that afzelin may help restore cell viability and reduce signs of aging in human skin cells. When combined with another compound, ganoderic acid A, afzelin showed promising results in lab experiments.
Why it matters: This study may help us better understand how to protect skin from the effects of UVA rays, which can contribute to premature aging.
This study was conducted in lab experiments using human skin cells and animal models, and the results may not translate directly to human skin. Further research is needed to confirm these findings.
In VitroCell or tissue culture experiments. No human or animal data.RetinolPublished: January 1, 2026
New Photostabilizer May Help Protect Retinol in Cosmetic Formulations
Researchers developed a supramolecular photostabilizer and tested whether it could reduce light-driven degradation of carotenoids and retinol in aqueous systems, creams, and an artificial skin model. The additive significantly reduced retinol photodegradation and appeared to work through a self-sacrificial radical-scavenging mechanism. The results suggest a possible way to improve retinol stability in cosmetic products.
Why it matters: Retinol stability is a major formulation problem, so better photostabilization could improve how reliably retinol products perform over time.
This was formulation and model-system research, not a clinical study showing better skin outcomes in people using a finished product.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: January 1, 2026
Safety of rhPDGF-BB for Skin Regeneration and Rejuvenation
Researchers studied the safety of a growth factor called rhPDGF-BB for skin regeneration and rejuvenation. They found that it was noncytotoxic, nonirritating, and non-toxic when applied topically or injected into the skin. However, more research is needed to confirm these findings.
Why it matters: Understanding the safety of rhPDGF-BB may help skincare professionals and consumers make informed decisions about its use.
Based on a review of existing studies, including both nonclinical and clinical pharmacokinetic and safety studies. The review did not include new, original research data.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Vitamin C (L-Ascorbic Acid)Published: January 1, 2026
Combining Antioxidant Serum with Microneedling May Help Improve Facial Rejuvenation
Researchers studied whether combining a topical antioxidant serum with microneedling treatments can improve facial rejuvenation. They found that in a small group of adults, the combination treatment may help reduce signs of aging, such as wrinkles and skin discoloration. However, more research is needed to confirm these findings.
Why it matters: This study may help skincare professionals and individuals understand how to optimize facial rejuvenation treatments.
A small, 31-participant study with a short 12-week duration and limited follow-up. The study's results may not be generalizable to a larger population.